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Abstract
Variation in the melanocortin-1receptor (MC1R) gene is associated with pigmentary pheno-
types and risk of malignant melanoma. Few studies have reported onMC1R variation with
respect to tumor characteristics, especially clinically important prognostic features. We ex-
amined associations betweenMC1R variants and histopathological melanoma characteris-
tics. Study participants were enrolled from nine geographic regions in Australia, Canada,
Italy and the United States and were genotyped forMC1R variants classified as high-risk
[R] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion) or
low-risk [r] (all other nonsynonymous) variants. Tissue was available for 2,160 white partici-
pants of the Genes, Environment and Melanoma (GEM) Study with a first incident primary
melanoma diagnosis, and underwent centralized pathologic review. No statistically signifi-
cant associations were observed betweenMC1R variants and AJCC established prognos-
tic tumor characteristics: Breslow thickness, presence of mitoses or presence of ulceration.
However,MC1R was significantly associated with anatomic site of melanoma (p = 0.002)
and a positive association was observed between carriage of more than one [R] variant and
melanomas arising on the arms (OR = 2.39; 95% CI: 1.40, 4.09). We also observed statisti-
cally significant differences between sun-sensitive and sun-resistant individuals with re-
spect to associations betweenMC1R genotype and AJCC prognostic tumor characteristics.
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Introduction
Inherited variation in the melanocortin-1 receptor (MC1R) gene is a robust genetic marker for
moderately increased risk of melanoma [1]. We hypothesize that variation inMC1R influences
the occurrence of melanomas that can be distinguished by histology or other tumor character-
istics. However, evidence supporting a consistent association betweenMC1R variation and
melanoma tumor characteristics is limited. Direct cross-study comparisons are hindered due
in part to a lack of standardized measures and characterization ofMC1R risk variants [2], cou-
pled with differences in categorization of melanoma characteristics (e.g. collapsing of anatomic
site presentation).
To more thoroughly address whetherMC1R variants are associated with tumor characteris-
tics, we present results from individuals diagnosed with a first incident primary tumor in a
large population-based case-control study of melanoma: the Genes, Environment and Melano-
ma (GEM) Study. We examined associations between variation inMC1R and American Joint
Committee on Cancer (AJCC) established tumor characteristics that are associated with prog-
nosis: Breslow thickness and presence of mitoses and ulceration [3–8], as well as with presence
of tumor infiltrating lymphocytes (TILs), a purported prognostic factor [9]. We also evaluated
other histopathological tumor features for associations withMC1R variation in an effort to fur-
ther characterize potential etiologic heterogeneity.
Materials and Methods
GEM Study
The GEM Study is a population-based case-control study that enrolled a large series of individ-
uals diagnosed with a first incident invasive primary cutaneous melanoma. Study participants
were identified from eight population-based cancer registries and one hospital center in Austra-
lia, Canada, Italy and the United States. Detailed study recruitment methods have been previ-
ously described [10,11]. The human research oversight committees at each of the GEM study
sites, including those at the British Columbia Cancer Agency, Vancouver, BC, CA; Cancer Care
Ontario, Toronto, ON, CA; Centro per la Prevenzione Oncologia, Torino, IT; Memorial Sloan
Kettering Cancer Center, New York, NY, US; Menzies Cancer Center, Hobart, TAS, AU; Uni-
versity of California, Irvine, CA, US; University of Michigan, Ann Arbor, MI, US; University of
North Carolina, Chapel Hill, NC, US; and University of Sydney, Sydney, NSW, AU, approved
the study protocol. Written and signed informed consent was obtained from all participants.
Diagnostic pathology reports were obtained for each participant with a first incident prima-
ry melanoma (n = 2,424) from the appropriate ascertainment center, and data corresponding
to histological subtype, lesion thickness, and anatomic location of lesion were abstracted.
Tumor tissue slides for 2,105 (86.8%) participants with a diagnosis of first incident melanoma
were available for centralized pathological review, performed in large part by one of three study
pathologists (KB, LF, PG). Standardized pathologic review of slides included evaluation of: his-
tologic subtype, Breslow thickness, Clark level, mitoses, solar elastosis, TILs, presence of satel-
lite lesions, presence of coexisting nevi, presence of pigmentation, evidence of lesion
regression, ulceration, and vertical growth phase. Melanomas were classified according to es-
tablished histopathological criteria [12,13]. Since Breslow thickness was both abstracted from
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the pathology report and recorded during the centralized pathologic review, the measure corre-
sponding to the deepest reading was chosen to represent the value of most biological relevance.
Using a glossy colored guide to aid in differentiating between nevi and other skin lesions, par-
ticipants were asked to have the nevi on their backs counted by a family member or friend; logis-
tic models were adjusted for this continuous variable. A phenotypic index was derived using
data collected from a study participant self-administered questionnaire [14], and was based on:
hair color (black or dark brown = 1; light brown or blond = 2; red = 3), eye color (black or
brown = 0; all other colors = 1), and relative inability to tan in response to sun exposure (no = 0;
yes = 1) [15]. Phenotypic index scores of 1 and 2 indicate relatively darker cutaneous phenotypes
and lower phenotypic melanoma risk; an index score of 3 indicates medium phenotypic risk.
Hereinafter, we refer to individuals with any of these three scores as having a “sun-resistant”
phenotype. Phenotypic index scores of 4 and 5 indicate relatively fairer cutaneous phenotypes
and higher phenotypic risks for melanoma, hereinafter referred to as “sun sensitive”.
MC1RGenotyping
Details ofMC1R genotyping methods, distribution of observedMC1R variants, and variant
carrier status among GEM Study participants have been described previously [15,16]. We
adopted nomenclature and definitions based on previous literature [1,17–20] to classifyMC1R
variants as conferring higher risk for melanoma based on strong association with red hair phe-
notype [R] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion)
or lower risk for melanoma based on weaker association with red hair phenotype [r] (all other
nonsynonymous variants). Since the exact functional status of manyMC1R variants is still un-
known, we acknowledge that these risk categories may be inaccurate. We categorizedMC1R
carriage into four groups: consensus (absence of any variants), only [r] (carriage of any [r] vari-
ant in the absence of a [R] variant), one [R] (carriage of a single [R] variant), and>1 [R] (car-
riage of more than 1 [R] variant). Secondarily, we examined associations betweenMC1R
variant carriage number and tumor characteristics by codingMC1R genotype based on total
number of variants ([r] and [R]; 0 variants vs. 1 variant vs. 2 or more variants).
Statistical Analysis
For this report, we include only those GEM participants with first incident primary melanomas
who were successfully genotyped forMC1R and who self-reported their race as white
(n = 2,160). We used SAS (SAS Institute, Cary, NC) to perform multinomial logistic regression
to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between
MC1R variant status and tumor characteristics while adjusting for sex, age at most recent mela-
noma diagnosis, study ascertainment center, phenotypic index and number of nevi on the back.
For tumor characteristics that were modeled dichotomously, results are equivalent to those ob-
tained from a binomial logistic regression model. We also conducted analyses stratified by sun-
resistant and sun-sensitive phenotypes; we then evaluated the Wald p-value of the interaction
term for sun sensitivity byMC1R to assess heterogeneity of effect between sun-sensitive and
sun-resistant phenotypes. All statistical tests were two-sided with an alpha level of 0.05.
Results
Overall, tumor characteristics were not associated with genotyping success (data not shown).
In univariate analyses, we compared the distributions ofMC1R genotype risk categories across
strata of prognostic tumor characteristics including: Breslow thickness and presence of mitoses,
ulceration, or TILs. No statistically significant associations were noted among these tumor
characteristics. We did observe a statistically significant association between anatomical site
MC1R and Melanoma Tumor Characteristics
PLOS ONE | DOI:10.1371/journal.pone.0119920 March 19, 2015 3 / 10
andMC1R variant carriage based on low-[r] and high-[R] risk variant carriage (p = 0.002)
(Table 1). Our findings with respect toMC1R variant carriage number were consistent with no
association (data not tabulated).
Multivariate analyses are also presented in Table 1. No statistically significant associations
were noted among prognostic tumor characteristics. However, our adjusted analyses revealed a
strong association between carriage of more than oneMC1R [R] variant and melanoma devel-
opment on the arms (OR = 2.39; 95% CI: 1.40, 4.09) when compared to individuals who devel-
oped melanomas on the trunk or pelvis. Associations betweenMC1R variants and strata of
other melanoma tumor characteristics were consistent with no association after adjustment.
Because previous reports have indicated that melanoma risk associated with carriage of
high-risk [R]MC1R variants is particularly informative among individuals with darker pheno-
typic characteristics [21], we explored associations betweenMC1R variants and the four prog-
nostic tumor characteristics by skin pigmentation phenotype. We noted statistical
heterogeneity between individuals with sun-sensitive and sun-resistant phenotypes for the as-
sociations betweenMC1R variants and Breslow thickness (p = 0.03), presence of mitoses
(p = 0.03), presence of ulceration (p = 0.04), as well as presence of TILs (p = 0.01) (Table 2).
We observed relatively stronger associations between Breslow thickness andMC1R among
sun-sensitive individuals. Similarly, we noted pronounced positive associations between car-
riage of only [r] variants (vs. carriage of only consensus) and presence of mitoses and ulcera-
tion among sun-sensitive individuals, whereas carriage of only [r] variants among sun-resistant
participants showed little or no association with presence of mitoses and an inverse association
with presence of ulceration. We found carriage of [R] variants was more prevalent among sun-
sensitive individuals with non-brisk TILs observed in their melanomas compared to sun-
resistant individuals with non-brisk TILs. In contrast, both [r] and [R] variants were more
prevalent among sun-resistant cases with brisk TILs observed in their lesions compared to sun-
sensitive cases with brisk TILs.
Discussion
The GEM Study provides well-annotated histopathological data for melanomas and complete
sequencing of participant DNA at theMC1R locus, which allows for a comprehensive examina-
tion of the associations between variants and histopathological tumor characteristics. In this
study we report no pronounced or statistically significant main effect associations ofMC1R
with AJCC accepted prognostic factors of Breslow thickness, presence of ulceration, or pres-
ence of mitoses overall. Similarly, we did not observe an association between variation in
MC1R and TILs, which were shown to be an important independent prognostic feature of mel-
anoma in GEM [9].
However, we did find a persistent positive association between carriage of more than one
[R] variant and melanoma presentation on the arms after adjustment. After stratification by
skin pigmentation phenotype, this observed association was limited to individuals with sun-
resistant phenotypes. There are several previous reports ofMC1R variation in association with
anatomical site of melanoma, but they generally grouped sites together on the basis of sun-
exposure before analyses and/or categorizedMC1R variants differently, [22–26] and are not di-
rectly comparable to this study. We did attempt to draw a comparison between our results and
results from a case-control study of sporadic and familial melanoma in a Swedish population
[25], which reported an increased association between carriage of1MC1R variant and mela-
noma presentation on the trunk (OR = 1.54; 95% CI: 1.01, 2.37). After recapitulating their cod-
ing for anatomic site,MC1R, and other covariates to the best of our ability, we were unable to
replicate that finding (data not shown). Recently, Peña-Vilabelda et. al. reported results similar
MC1R and Melanoma Tumor Characteristics
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to our own with respect to high-riskMC1R variants in association with melanoma tumor site
presentation (Arms: OR = 2.34; 95% CI: 0.98, 5.61) [27]. Interestingly, prior studies have noted
more favorable prognoses among melanomas presenting on the extremities [28,29]. Future
studies of variation inMC1R related to anatomical melanoma presentation are necessary to
validate our findings.
We explored effect modification by phenotypic index only among the prognostic measures
of Breslow thickness, ulceration, mitoses, and TILs to limit the potential for false discovery. We
observed significant differences between phenotypically sun-resistant and sun-sensitive indi-
viduals with respect to all four prognostic tumor factors. Interestingly, sun-sensitive cases dem-
onstrated stronger associations across Breslow thickness, mitoses and ulceration compared to
those observed among sun-resistant individuals. These results are thought-provoking consider-
ing that it is among individuals with more sun-resistant phenotypes thatMC1R has been asso-
ciated with increased risk for melanoma [21,30]. However, we did note generally stronger
associations between brisk TILs andMC1R among individuals with a sun-resistant phenotype
compared to sun-sensitive cases. Although associations betweenMC1R variant carriage and all
four prognostic variables were significantly different between phenotypic classifications, we
were likely underpowered to detect associations within strata of phenotypic index despite the
large sample size available in the GEM Study.
This investigation of tumor characteristics among 2,160 first incident cases of melanoma is
the largest such study to examine associations with germline variation inMC1R. A strength of
this study is the population-based nature of the parent GEM Study, from which a large number
of incident cases were drawn from nine international ascertainment centers, improving gener-
alizability of results to persons of European ancestry living in a variety of climates. Other advan-
tages of this investigation were the centralized histopathological review conducted by expert
pathologists and the ability to adjust for the potential impact of skin pigment and number of
nevi. However, we do acknowledge the possibility that false positive findings may have arisen
due to multiple hypothesis testing and the exploratory nature of associations examined between
MC1R variation and tumor factors stratified by phenotypic index; thus, these findings should
be validated in larger study populations before more meaningful interpretations can be made.
Acknowledgments
The study was conducted by the GEM Study Group: Coordinating Center, Memorial Sloan
Kettering Cancer Center, New York, NY, USA: Marianne Berwick (PI, currently at the Univer-
sity of New Mexico), Colin Begg (Co-PI), Irene Orlow (Co-Investigator), Klaus Busam (Der-
matopathologist), Anne S. Reiner (biostatistician), Emily La Pilla (Laboratory Technician),
Pampa Roy (Laboratory Technician). University of New Mexico, Albuquerque, NM (USA):
Marianne Berwick (PI), Li Luo (biostatistician), Kirsten White (Laboratory Manager), Susan
Paine (Data Manager). Study Centers: The University of Sydney and the Cancer Council New
South Wales, Sydney (Australia): Bruce Armstrong (PI), Anne Kricker (Co-PI), Anne Cust
(Co-investigator). Menzies Research Institute Tasmania, University of Tasmania, Hobart (Aus-
tralia): Alison Venn (Current PI), Terence Dwyer (PI, currently at International Agency for Re-
search on Cancer, Lyon, France), Paul Tucker (Dermatopathologist). British Columbia Cancer
Research Centre, Vancouver, British Columbia (Canada): Richard Gallagher (PI), Donna Kan
(Coordinator). Cancer Care Ontario, Toronto, Ontario (Canada): Loraine Marrett (PI), Eliza-
beth Theis (Co-Investigator), Lynn From (Dermatopathologist). Centro per la Prevenzione
Oncologia Torino, Piemonte (Italy): Roberto Zanetti (PI), Stefano Rosso (Data Manager). Uni-
versity of California, Irvine (USA): Hoda Anton-Culver (PI), Argyrios Ziogas (Statistician).
University of Michigan, Ann Arbor (USA): Stephen Gruber (PI, currently at University of
MC1R and Melanoma Tumor Characteristics
PLOS ONE | DOI:10.1371/journal.pone.0119920 March 19, 2015 8 / 10
Southern California, Los Angeles, CA), Timothy Johnson (Director of Melanoma Program),
Shu-Chen Huang (Co-investigator, joint at USC-University of Michigan). New Jersey Depart-
ment of Health and Senior Services, Trenton (USA): Judith Klotz (PI, currently retired),
Homer Wilcox (Co-PI, currently retired). University of North Carolina, Chapel Hill, NC
(USA): Nancy Thomas (PI), Robert Millikan (previous PI, deceased), David Ollila
(Co-investigator), Kathleen Conway (Co-investigator), Pamela Groben (Dermatopathologist),
Sharon Edmiston (Research Analyst), Honglin Hao (Laboratory Specialist), Eloise Parrish
(Laboratory Specialist), Jill Frank (Research Assistant). University of Pennsylvania, Philadel-
phia, PA (USA): Timothy Rebbeck (PI), Peter Kanetsky (Co-investigator).
Author Contributions
Conceived and designed the experiments: CBB MB PAK NJT. Performed the experiments: KJB
LF PAG PAK TRR. Analyzed the data: PAK NJT. Contributed reagents/materials/analysis
tools: PAK TRR NJT. Wrote the paper: KJB AEC HAC TD LF PAG RPG SBG PAK IO SR
NET NJT RZ.
References
1. Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, et al. MC1R variants, melanoma
and red hair color phenotype: a meta-analysis. Int J Cancer. 2008; 122: 2753–2760. doi: 10.1002/ijc.
23396 PMID: 18366057
2. Williams PF, Olsen CM, Hayward NK, Whiteman DCMelanocortin 1 receptor and risk of cutaneous
melanoma: a meta-analysis and estimates of population burden. Int J Cancer. 2011; 129: 1730–1740.
doi: 10.1002/ijc.25804 PMID: 21128237
3. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009
AJCCmelanoma staging and classification. J Clin Oncol. 2009; 27: 6199–6206. doi: 10.1200/JCO.
2009.23.4799 PMID: 19917835
4. Barnhill RL, Fine JA, Roush GC, Berwick M Predicting five-year outcome for patients with cutaneous
melanoma in a population-based study. Cancer. 1996; 78: 427–432. PMID: 8697387
5. Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, et al. Tumor mitotic rate is a
more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an
analysis of 3661 patients from a single center. Cancer. 2003; 97: 1488–1498. PMID: 12627514
6. Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, et al. Identification of high-risk pa-
tients among those diagnosed with thin cutaneous melanomas. J Clin Oncol. 2007; 25: 1129–1134.
PMID: 17369575
7. Day CL Jr., Sober AJ, Kopf AW, Lew RA, MihmMC Jr., Golomb FM, et al. A prognostic model for clinical
stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent
disease. Am J Surg. 1981; 142: 247–251. PMID: 7258536
8. Clark WH Jr., Elder DE, Guerry Dt, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in
stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989; 81: 1893–1904. PMID:
2593166
9. Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, et al. Tumor-infiltrating lym-
phocyte grade in primary melanomas is independently associated with melanoma-specific survival in
the population-based genes, environment and melanoma study. J Clin Oncol. 2013; 31: 4252–4259.
doi: 10.1200/JCO.2013.51.3002 PMID: 24127443
10. Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, et al. Polymorphisms in nucleotide
excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma
Study. Carcinogenesis. 2006; 27: 610–618. PMID: 16258177
11. Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. A design for cancer
case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epi-
demiol. 2006; 35: 756–764. PMID: 16556646
12. Clark WH Jr., From L, Bernardino EA, MihmMC The histogenesis and biologic behavior of primary
human malignant melanomas of the skin. Cancer Res. 1969; 29: 705–727. PMID: 5773814
13. McGovern VJ, MihmMC Jr., Bailly C, Booth JC, Clark WH Jr., Cochran AJ, et al. The classification of
malignant melanoma and its histologic reporting. Cancer. 1973; 32: 1446–1457. PMID: 4757934
MC1R and Melanoma Tumor Characteristics
PLOS ONE | DOI:10.1371/journal.pone.0119920 March 19, 2015 9 / 10
14. Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of
melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control.
2004; 15: 957–965. PMID: 15577298
15. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, et al. Population-
based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res.
2006; 66: 9330–9337. PMID: 16982779
16. Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, et al. Assessment of polymorphic
variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary ap-
proach. Cancer Epidemiol Biomarkers Prev. 2004; 13: 808–819. PMID: 15159314
17. Sturm RA, Duffy DL, Box NF, ChenW, Smit DJ, Brown DL, et al. The role of melanocortin-1 receptor
polymorphism in skin cancer risk phenotypes. Pigment Cell Res. 2003; 16: 266–272. PMID: 12753400
18. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, BergmanW, et al. Melanocortin 1 receptor
(MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely
independent of skin type and hair color. J Invest Dermatol. 2001; 117: 294–300. PMID: 11511307
19. Schioth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL Loss of function mutations
of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys
Res Commun. 1999; 260: 488–491. PMID: 10403794
20. Flanagan N, Healy E, Ray A, Philips S, Todd C, Jackson IJ, et al. Pleiotropic effects of the melanocortin
1 receptor (MC1R) gene on human pigmentation. HumMol Genet. 2000; 9: 2531–2537. PMID:
11030758
21. Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, et al. Does MC1R genotype
convey information about melanoma risk beyond risk phenotypes? Cancer. 2010; 116: 2416–2428.
doi: 10.1002/cncr.24994 PMID: 20301115
22. Debniak T, Scott R, Masojc B, Serrano-Fernandez P, Huzarski T, Byrski T, et al. MC1R common vari-
ants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer. 2006; 119:
2597–2602. PMID: 16988943
23. Stratigos AJ, Dimisianos G, Nikolaou V, Poulou M, Sypsa V, Stefanaki I, et al. Melanocortin receptor-1
gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
J Invest Dermatol. 2006; 126: 1842–1849. PMID: 16601669
24. Ichii-Jones F, Lear JT, Heagerty AH, Smith AG, Hutchinson PE, Osborne J, et al. Susceptibility to mela-
noma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene.
J Invest Dermatol. 1998; 111: 218–221. PMID: 9699720
25. Hoiom V, Tuominen R, Kaller M, Linden D, Ahmadian A, Mansson-Brahme E, et al. MC1R variation
and melanoma risk in the Swedish population in relation to clinical and pathological parameters. Pig-
ment Cell Melanoma Res. 2009; 22: 196–204. doi: 10.1111/j.1755-148X.2008.00526.x PMID:
19077144
26. Cust AE, Goumas C, Holland EA, Agha-Hamilton C, Aitken JF, Armstrong BK, et al. MC1R genotypes
and risk of melanoma before age 40 years: a population-based case-control-family study. Int J Cancer.
2012; 131: E269–281. doi: 10.1002/ijc.27357 PMID: 22095472
27. Pena-Vilabelda MM, Garcia-Casado Z, Requena C, Traves V, Lopez-Guerrero JA, Guillen C, et al. Clin-
ical characteristics of patients with cutaneous melanoma according to variants in the melanocortin 1 re-
ceptor gene. Actas Dermosifiliogr. 2014; 105: 159–171. doi: 10.1016/j.ad.2013.10.001 PMID:
24238329
28. Mervic L Prognostic factors in patients with localized primary cutaneous melanoma. Acta Dermatove-
nerol Alp Panonica Adriat. 2012; 21: 27–31. PMID: 23000937
29. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, et al. Prognostic implica-
tions of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg. 2011; 202:
659–664; discussion 664–655. doi: 10.1016/j.amjsurg.2011.06.048 PMID: 22137134
30. Pasquali E, Garcia-Borron JC, Fargnoli MC, Gandini S, Maisonneuve P, Bagnardi V, et al. MC1R vari-
ants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-
analysis from the M-SKIP project. Int J Cancer. 2014.
MC1R and Melanoma Tumor Characteristics
PLOS ONE | DOI:10.1371/journal.pone.0119920 March 19, 2015 10 / 10
